TC BioPharm Aktie
WKN DE: A3DEX4 / ISIN: US87807D1037
03.01.2024 15:28:00
|
TC BioPharm To Reduce Headcount By 50%
(RTTNews) - TC Biopharm (Holdings) Plc. (TCBP), a clinical-stage biopharmaceutical company, Wednesday announced its plan to lay off workers by 50% to reduce costs and expand its cash runway.
The company also intends to utilize Research and Development only for the development of commercial applications and manufacturing.
The company said that these measures would help to complete the ACHIEVE trial in 2024.
In the pre-market activity, TC BioPharm's stock climbed by 2.19%, to $3.1984 on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu TC BioPharm (Holdings) PLC (spons. ADRs)mehr Nachrichten
Keine Nachrichten verfügbar. |